Schedule 13G ownership disclosure
Intellia Therapeutics Inc
Common Stock · CUSIP: 45826J105
Event date: 2025-12-31
- Filing-level shares
- 13,010,001
- Percent of class
- 11.23%
- The Vanguard Group
Shares: 13,010,001 · Class: 11.23%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000156
- Form type
- SCHEDULE 13G/A
- Filer
- Intellia Therapeutics, Inc.
- CIK
- CIK 1652130
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership